Skip to main content
Equibles
ALEC logo

ALEC · Alector, Inc. · Metrics

Track ALEC — free

Use ALEC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALEC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.14 +0.00 (+0.00%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$238.95M
Shares
111.66M

ALEC metrics

67 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.14
Market cap
$238.95M

Price action

20 metrics
Price change (1W)
-13.0%
Price change (30D)
+9.2%
Price change (3M)
+39.9%
Price change (6M)
-2.7%
Price change (YTD)
+37.2%
Price change (1Y)
-25.4%
Trailing year
Price change (5Y)
-90.6%
52-week high
$3.32
52-week low
$1.14
Change from 52-week high
-35.5%
Change from 52-week low
+87.7%
Annualized volatility
95.8%
Annualized volatility (3M)
105.4%
Beta
1.8
RSI (14D)
47.9
Price vs SMA 50
+11.3%
Price vs SMA 200
+10.1%
Avg volume (3M)
1.15M
Relative volume
4.1
Average dollar volume
$2.31M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
111.66M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
5.5×
reciprocal yield 18.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
17.2×
reciprocal yield 5.8%
P / book
—
FCF yield
-66.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-49.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
-0.7×
EV / revenue historical average (5Y)
-0.7×
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-08-07

Profitability

9 metrics
Gross margin
—
Operating margin
-912.4%
Trailing 12 months
Net margin
-850.1%
Gross profit (TTM)
—
Operating profit (TTM)
−$126.49M
Net income (TTM)
−$117.85M
Trailing 12 months
Diluted EPS (TTM)
$-1.10
FCF margin
-1,142.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.28

Growth

11 metrics
Revenue growth YoY
-57.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$13.86M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+10.8%
Year over year · more shares
Revenue CAGR (3Y)
-46.0%
Revenue CAGR (5Y)
-0.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-58.1%
Debt / equity
—
Current ratio
5.3
EBITDA (TTM)
−$121.95M
Free cash flow (TTM)
−$158.39M
Quick ratio
5.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$162.95M
Latest balance sheet
Cash & equivalents
$59.91M
Total assets
$202.85M
Total debt
$9.85M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$158.23M
Capital expenditures (TTM)
$160,000
R&D (TTM)
$99.13M
SG&A (TTM)
—
Stock compensation (TTM)
$16.76M
R&D / revenue
715.1%
Stock compensation / revenue
120.9%

Ownership (13F)

3 metrics
13F filers
141
13F filer change QoQ
+3
Institutional ownership
82.5%

Short interest

3 metrics
Short interest
5.5%
Latest settlement · 4.6 days to cover
Days to cover
4.6d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$296,087
Insider-sentiment score
27 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1653087 CUSIP 014442107 13F (30d) 60 filings 60 filers Visit website Investor relations